1. Home
  2. FARO vs STOK Comparison

FARO vs STOK Comparison

Compare FARO & STOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FARO
  • STOK
  • Stock Information
  • Founded
  • FARO 1981
  • STOK 2014
  • Country
  • FARO United States
  • STOK United States
  • Employees
  • FARO N/A
  • STOK N/A
  • Industry
  • FARO Industrial Machinery/Components
  • STOK Biotechnology: Pharmaceutical Preparations
  • Sector
  • FARO Industrials
  • STOK Health Care
  • Exchange
  • FARO Nasdaq
  • STOK Nasdaq
  • Market Cap
  • FARO 808.5M
  • STOK 517.0M
  • IPO Year
  • FARO 1997
  • STOK 2019
  • Fundamental
  • Price
  • FARO $42.37
  • STOK $9.54
  • Analyst Decision
  • FARO Buy
  • STOK Strong Buy
  • Analyst Count
  • FARO 2
  • STOK 5
  • Target Price
  • FARO $35.50
  • STOK $24.50
  • AVG Volume (30 Days)
  • FARO 1.5M
  • STOK 694.7K
  • Earning Date
  • FARO 04-24-2025
  • STOK 05-13-2025
  • Dividend Yield
  • FARO N/A
  • STOK N/A
  • EPS Growth
  • FARO N/A
  • STOK N/A
  • EPS
  • FARO N/A
  • STOK 0.88
  • Revenue
  • FARO $341,046,000.00
  • STOK $190,908,000.00
  • Revenue This Year
  • FARO $3.49
  • STOK $44.17
  • Revenue Next Year
  • FARO $5.72
  • STOK $20.00
  • P/E Ratio
  • FARO N/A
  • STOK $10.88
  • Revenue Growth
  • FARO N/A
  • STOK 2333.81
  • 52 Week Low
  • FARO $13.52
  • STOK $5.35
  • 52 Week High
  • FARO $42.64
  • STOK $17.58
  • Technical
  • Relative Strength Index (RSI)
  • FARO 78.62
  • STOK 54.33
  • Support Level
  • FARO $41.96
  • STOK $9.09
  • Resistance Level
  • FARO $42.22
  • STOK $9.83
  • Average True Range (ATR)
  • FARO 0.24
  • STOK 0.62
  • MACD
  • FARO -0.41
  • STOK -0.05
  • Stochastic Oscillator
  • FARO 60.29
  • STOK 48.19

About FARO FARO Technologies Inc.

Faro Technologies Inc is a technology company. It designs, develops, manufactures, markets and supports software-driven, three-dimensional (3-D) measurement, imaging, and realization solutions for the 3D metrology, architecture, engineering and construction (AEC), Operations and Maintenance (O&M) and public safety analytics markets. The company enables its customers to capture, measure, manipulate, interact with and share 3D and 2D data from the physical world in a virtual environment and then translate the information back into the physical domain. FARO suite of 3D products and software solutions are used for the inspection of components and assemblies, rapid prototyping, reverse engineering, documenting large volumes or structures in 3D, surveying, and construction.

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

Share on Social Networks: